Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on February 4, 2021, to announce its financial results for the fourth quarter and full year ended December 31, 2020. The report primarily serves to furnish the company's earnings press release, which contains detailed financial performance information. Investors should refer to Exhibit 99.1 of this filing for the comprehensive earnings release. The company highlights that it presents financial information on both a GAAP and a non-GAAP basis. Management utilizes non-GAAP measures for internal operational and financial planning, viewing them as supplementary tools for investors to better understand the company's performance when analyzed alongside GAAP figures. A reconciliation between GAAP and non-GAAP metrics is available within the provided press release.
Key Highlights
- 1Gilead Sciences announced its Q4 and full-year 2020 financial results via an 8-K filing on February 4, 2021.
- 2The core of the filing is the earnings press release (Exhibit 99.1), containing detailed financial outcomes.
- 3Gilead reports its financial results using both GAAP and non-GAAP measures.
- 4The company emphasizes that non-GAAP information is provided as a supplement for investor understanding and is used internally for operational and financial planning.
- 5Investors are directed to the press release for a reconciliation between GAAP and non-GAAP financial information.
- 6The information furnished in this 8-K and its exhibit is not considered 'filed' for purposes of Section 18 of the Exchange Act.